Home LiteratureArticle Details
PMID: 20190799 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Cross talk between stimulated NF-kappaB and the tumor suppressor p53.

Oncogene ·Vol. 29 ·No. 19 ·2010-05-13 ·Pages 2795-806

Schneider G, Henrich A, Greiner G, Wolf V, Lovas A, Wieczorek M, Wagner T, Reichardt S, von Werder A, Schmid RM, Weih F, Heinzel T, Saur D, Krämer OH

Abstract

Nuclear factor-kappaB (NF-kappaB) and p53 critically determine cancer development and progression. Defining the cross talk between these transcription factors can expand our knowledge on molecular mechanisms of tumorigenesis. Here, we show that induction of replicational stress activates NF-kappaB p65 and triggers its interaction with p53 in the nucleus. Experiments with knockout cells show that p65 and p53 are both required for enhanced NF-kappaB activity during S-phase checkpoint activation involving ataxia-telangiectasia mutated and checkpoint kinase-1. Accordingly, the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) also triggers formation of a transcriptionally active complex containing nuclear p65 and p53 on kappaB response elements. Gene expression analyses revealed that, independent of NF-kappaB activation in the cytosol, TNF-induced NF-kappaB-directed gene expression relies on p53. Hence, p53 is unexpectedly necessary for NF-kappaB-mediated gene expression induced by atypical and classical stimuli. Remarkably, data from gain- and loss-of function approaches argue that anti-apoptotic NF-kappaB p65 activity is constitutively evoked by a p53 hot-spot mutant frequently found in tumors. Our observations suggest explanations for the outstanding question why p53 mutations rather than p53 deletions arise in tumors of various origins.

MeSH Terms
Animals Apoptosis/drug effects Ataxia Telangiectasia Mutated Proteins Cell Cycle Proteins/metabolism Cell Line, Tumor Checkpoint Kinase 1 DNA/genetics,metabolism DNA Replication DNA-Binding Proteins/metabolism Gene Expression Regulation, Neoplastic/drug effects Humans Hydroxyurea/pharmacology Mice Mutation Protein Kinases/metabolism Protein Serine-Threonine Kinases/metabolism S Phase/drug effects Signal Transduction/drug effects Stress, Physiological/genetics Transcription Factor RelA/metabolism Transcription, Genetic/drug effects Transcriptional Activation/drug effects Tumor Necrosis Factor-alpha/metabolism Tumor Suppressor Protein p53/genetics,metabolism Tumor Suppressor Proteins/metabolism
Chemicals
Cell Cycle Proteins DNA-Binding Proteins Transcription Factor RelA Tumor Necrosis Factor-alpha Tumor Suppressor Protein p53 Tumor Suppressor Proteins DNA Protein Kinases ATM protein, human Ataxia Telangiectasia Mutated Proteins Atm protein, mouse CHEK1 protein, human Checkpoint Kinase 1 Chek1 protein, mouse Protein Serine-Threonine Kinases Hydroxyurea
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Schneider G
Klinikum rechts der Isar, II, Medizinische Klinik, Technische Universität München, München, Germany.
Henrich A
Greiner G
Wolf V
Lovas A
Wieczorek M
Wagner T
Reichardt S
von Werder A
Schmid R M
Weih F
Heinzel T
Saur D
Krämer O H
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
1476-5594
Published
2010-05-13
Epub
2010-00-01
Pages
2795-806
Language
English
Region
England
NLM ID
8711562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com